LEADER 01280nas  2200421-a 450 
001 9910141389903321
005 20240413015242.0
011   $a2045-0915
035   $a(CKB)2670000000263870
035   $a(CONSER)--2012243738
035   $a(MiAaPQ)3748001
035   $a(DE-599)ZDB2692808-5
035   $a(EXLCZ)992670000000263870
100   $a20100813a20129999  ---         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCNS oncology
210   $aLondon $cFuture Medicine$d2012-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $aPrint version: CNS oncology. (DLC)  2012243738 (OCoLC)815861288 2045-0907 
606   $aCentral nervous system$xTumors$vPeriodicals
606   $aCentral nervous system$xTumors$2fast$3(OCoLC)fst00850756
606   $aNervous System Neoplasms
608   $aPeriodicals.$2fast
608   $aPeriodical.
615  0$aCentral nervous system$xTumors
615  7$aCentral nervous system$xTumors.
615 12$aNervous System Neoplasms.
676   $a616.99481
906   $aJOURNAL
912   $a9910141389903321
920   $aexl_impl conversion
996   $aCNS oncology$92023960
997   $aUNINA